USPTO serial 88979269
CANNA HEMP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- DANTZLER, LAUREN ALEXANDRIA
- Law office
- TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with CANNA HEMP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Electronic cigarette liquid (e-liquid) comprised of essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Inedible natural essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all of the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Natural essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Inedible terpenes being essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all of the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Terpenes being essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Inedible essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all of the foregoing not intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease; Essential oils, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Non-medicated skin care creams and lotions, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated lip balms, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis; Non-medicated herbal body care products, namely, body oils, salves, and lip balms, the foregoing products containing hemp, hemp seed oil, or hemp-based material solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis | ACTIVE | — |
| 005 | Dietary supplements, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Dietary supplements for animals in the nature of orally-consumed nutritional feed supplements for animals, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Dietary supplements for pets in the nature of orally-consumed nutritional feed supplements for animals, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Dietary and nutritional supplements, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Medicated lip balm, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace amounts of CBD; Medicated lip balm, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring levels of CBD, and all of the foregoing not including any nutritional supplements or prescription pharmaceuticals, and all of the foregoing not including any OTC products containing CBD as an active ingredient; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring levels of CBD, and all of the foregoing not including any nutritional supplements or prescription pharmaceuticals, and all of the foregoing not including any OTC products containing CBD as an active ingredient; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring levels of CBD, and all of the foregoing not including any nutritional supplements or prescription pharmaceuticals, and all of the foregoing not including any OTC products containing CBD as an active ingredient; Dietary supplements, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Dietary supplements for animals in the nature of orally-consumed nutritional feed supplements for animals, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Dietary supplements for pets in the nature of orally-consumed nutritional feed supplements for animals, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Dietary and nutritional supplements, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated lip balm, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, the foregoing products containing hemp seed oil solely derived from cannabis with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 17, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 26, 2024 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Jan 26, 2024 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Jan 24, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 24, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 24, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 19, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Jan 19, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 19, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 19, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 9, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 6, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 10, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 10, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 23, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 23, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 23, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 12, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 12, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Oct 8, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 8, 2020 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 8, 2020 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 8, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Aug 25, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 20, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 19, 2020 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Aug 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 19, 2020 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Feb 20, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 23, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 23, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 23, 2020 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 14, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 13, 2020 | ALIE | ASSIGNED TO LIE | — |
| Dec 19, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 18, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 18, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 8, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 8, 2019 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Aug 8, 2019 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Jun 19, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 25, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 15, 2018 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Nov 15, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Nov 10, 2018 | NWAP | NEW APPLICATION ENTERED | — |